What I told Congress about Patient Access to Experimental Medicines

I recently testified at a hearing on “Examining Patient Access to Investigational Drugs,” where I used my time before legislators to tell them what I have learned after more than three years of intensive study about patient access to experimental medicines.

from Forbes Real Time https://www.forbes.com/sites/alisonbatemanhouse/2017/10/17/what-i-told-congress-about-patient-access-to-experimental-medicines/
via IFTTT